Avid Bioservices Inc (CDMO)

[cjgaddy]

1-29-18/NobleCon14: Roger Lias Presentation Webcast Link (20mins/24 Slides)

Jan29 2018: “NobleCon14 – Noble Financial’s 14th Annual Inv. Conf.”, Ft.Laud.
Conf. website: http://nobleconference.com
11:30amET: Roger J. Lias, PhD: Corporate presentation
WEBCAST Link - 20mins/24 Slides:
http://noble.mediasite.com/mediasite/Play/a4bbd41fda0d41ab9be7504f2a8eb7901d
http://ir.avidbio.com/events.cfm
Slide4 “Completed Key Elements of Transition”
2:26/RL: “...We are currently seeking to monetize the R&D assets, the remainder, some residual value we believe, and we hope to have news on that front very soon, and obviously that represents potential upside for stockholders over the short term.”


Slide15 “Near-term Plans for Growing the Business”
10:13/RL: “...We are expanding our sales & marketing. As I mentioned before, we haven’t been, for several years really, selling at all; there hasn’t been a need for it. So suddenly we’ve had to take that on, and I’m pleased to report that we’re already showing, really, tremendous progress in that area, and I hope we’ll have some announcements soon about several new clients.”


= = = = = = = = =EARLIER R.LIAS PRESENTATIONS:
1-18-18: ASM2017 (@Myford Facility) - Roger Lias’ Slideshow & Attendee Reports https://tinyurl.com/yca6enbr PROXY/14A: https://tinyurl.com/y7qprpg9

1-8-18/Roger Lias: EBD's Biotech Showcase 2018 (parallel w/JPM Conf.), SanFran - Slideshow: https://tinyurl.com/ya6tgxxa

12-11-17: Qtly. Conf. Call (Lias/Lytle) Transcript https://tinyurl.com/ybycb2s6
...Dr. Lias, "the company is undergoing a broad-scale transformation, the goals of which are to shift complete focus to the Avid Bioservices CDMO business and the complete divestiture of all of Peregrine's legacy R&D assets, which include bavituximab."

FULL HISTORY of PPHM-Ronin PR’s, Letters, 13-D’s, Form4’s, Proxy’s, etc: https://tinyurl.com/ycb3fpfm